Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Lisa Bero to Publishing

This is a "connection" page, showing publications Lisa Bero has written about Publishing.

 
Connection Strength
 
 
 
6.083
 
  1. Grundy Q, Dunn AG, Bero L. Improving researchers' conflict of interest declarations. BMJ. 2020 Mar 11; 368:m422.
    View in: PubMed
    Score: 0.646
  2. Ding D, Nguyen B, Gebel K, Bauman A, Bero L. Duplicate and salami publication: a prevalence study of journal policies. Int J Epidemiol. 2020 02 01; 49(1):281-288.
    View in: PubMed
    Score: 0.641
  3. Chiu K, Grundy Q, Bero L. 'Spin' in published biomedical literature: A methodological systematic review. PLoS Biol. 2017 Sep; 15(9):e2002173.
    View in: PubMed
    Score: 0.543
  4. Schroll J, Bero L. Regulatory agencies hold the key to improving Cochrane reviews of drugs. Cochrane Database Syst Rev. 2015 Apr 20; 4:ED000098.
    View in: PubMed
    Score: 0.460
  5. Siler K, Lee K, Bero L. Reply to Margalida and Colomer: Science should strive to prevent mistakes, not corrections. Proc Natl Acad Sci U S A. 2015 Mar 31; 112(13):E1512.
    View in: PubMed
    Score: 0.457
  6. Siler K, Lee K, Bero L. Measuring the effectiveness of scientific gatekeeping. Proc Natl Acad Sci U S A. 2015 Jan 13; 112(2):360-5.
    View in: PubMed
    Score: 0.450
  7. Wolfe N, G?tzsche PC, Bero L. Strategies for obtaining unpublished drug trial data: a qualitative interview study. Syst Rev. 2013 May 16; 2:31.
    View in: PubMed
    Score: 0.403
  8. Walleser S, Hill SR, Bero LA. Characteristics and quality of reporting of cluster randomized trials in children: reporting needs improvement. J Clin Epidemiol. 2011 Dec; 64(12):1331-40.
    View in: PubMed
    Score: 0.355
  9. Cook DM, Boyd EA, Grossmann C, Bero LA. Reporting science and conflicts of interest in the lay press. PLoS One. 2007 Dec 05; 2(12):e1266.
    View in: PubMed
    Score: 0.276
  10. Mowatt G, Shirran L, Grimshaw JM, Rennie D, Flanagin A, Yank V, MacLennan G, G?tzsche PC, Bero LA. Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA. 2002 Jun 05; 287(21):2769-71.
    View in: PubMed
    Score: 0.189
  11. Lee KP, Schotland M, Bacchetti P, Bero LA. Association of journal quality indicators with methodological quality of clinical research articles. JAMA. 2002 Jun 05; 287(21):2805-8.
    View in: PubMed
    Score: 0.189
  12. Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: a review. J Clin Epidemiol. 2020 06; 122:1-11.
    View in: PubMed
    Score: 0.161
  13. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998 May 20; 279(19):1566-70.
    View in: PubMed
    Score: 0.142
  14. Barnes DE, Bero LA. Scientific quality of original research articles on environmental tobacco smoke. Tob Control. 1997; 6(1):19-26.
    View in: PubMed
    Score: 0.129
  15. Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Intern Med. 1996 Mar 01; 124(5):485-9.
    View in: PubMed
    Score: 0.122
  16. Bero L, Rennie D. The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care. JAMA. 1995 Dec 27; 274(24):1935-8.
    View in: PubMed
    Score: 0.121
  17. Mahady SE, Schlub T, Bero L, Moher D, Tovey D, George J, Craig JC. Side effects are incompletely reported among systematic reviews in gastroenterology. J Clin Epidemiol. 2015 Feb; 68(2):144-53.
    View in: PubMed
    Score: 0.110
  18. Schroll JB, Bero L, G?tzsche PC. Searching for unpublished data for Cochrane reviews: cross sectional study. BMJ. 2013 Apr 23; 346:f2231.
    View in: PubMed
    Score: 0.100
  19. Bero LA, Ghersi D. Making systematic reviews global. Cochrane Database Syst Rev. 2011 Feb 16; (8):ED000020.
    View in: PubMed
    Score: 0.086
  20. Rasmussen N, Lee K, Bero L. Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials. 2009 Dec 16; 10:116.
    View in: PubMed
    Score: 0.079
  21. Hong MK, Bero LA. Tobacco industry sponsorship of a book and conflict of interest. Addiction. 2006 Aug; 101(8):1202-11.
    View in: PubMed
    Score: 0.063
  22. Hong MK, Bero LA. How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ. 2002 Dec 14; 325(7377):1413-6.
    View in: PubMed
    Score: 0.049
  23. Rochon PA, Bero LA, Bay AM, Gold JL, Dergal JM, Binns MA, Streiner DL, Gurwitz JH. Comparison of review articles published in peer-reviewed and throwaway journals. JAMA. 2002 Jun 05; 287(21):2853-6.
    View in: PubMed
    Score: 0.047
  24. Lexchin J, Bero LA, Davis C, Gagnon MA. Achieving greater independence from commercial influence in research. BMJ. 2021 03 09; 372:n370.
    View in: PubMed
    Score: 0.043
  25. Bero LA, Rennie D. Influences on the quality of published drug studies. Int J Technol Assess Health Care. 1996; 12(2):209-37.
    View in: PubMed
    Score: 0.030
  26. Hornbein T, Bero L, Rennie D. The publication of commercially supported supplements statement. Anesth Analg. 1995 Oct; 81(4):887-8; author reply 888-9.
    View in: PubMed
    Score: 0.030
  27. Chang L, Dhruva SS, Chu J, Bero LA, Redberg RF. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports. BMJ. 2015 Jun 10; 350:h2613.
    View in: PubMed
    Score: 0.029
  28. Cho MK, Bero LA. Instruments for assessing the quality of drug studies published in the medical literature. JAMA. 1994 Jul 13; 272(2):101-4.
    View in: PubMed
    Score: 0.027
  29. Bero LA, Glantz SA, Rennie D. Publication bias and public health policy on environmental tobacco smoke. JAMA. 1994 Jul 13; 272(2):133-6.
    View in: PubMed
    Score: 0.027
  30. Bero LA, Galbraith A, Rennie D. Sponsored symposia on environmental tobacco smoke. JAMA. 1994 Feb 23; 271(8):612-7.
    View in: PubMed
    Score: 0.027
  31. Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA. 2011 Mar 09; 305(10):1008-17.
    View in: PubMed
    Score: 0.022
  32. Steinman MA, Bero LA, Chren MM, Landefeld CS. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med. 2006 Aug 15; 145(4):284-93.
    View in: PubMed
    Score: 0.016
  33. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003 May 31; 326(7400):1167-70.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)